Diabetes patients treated with metformin—the drug that has been used to treat diabetes for more than six decades—have been reported to have their risk of cancer reduced by around 40% compared with other diabetics. During the Annual meeting of the EASD, the European Association for the Study of Diabetes (September 22 - 24, Stockhom, Sweden), Professor Michael Pollak, McGill University, Montreal, Canada, showed that evidence suggesting that the commonly-used antidiabetic drug may be… Continue
Added by Peter Hofland, PhD on September 22, 2010 at 10:30am —
No Comments